Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Moffat
L E
LE
Aberdeen Royal Infirmary, UK.
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D001940:Breast / Q000187:drug effects; D002064:Buserelin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003534:Cyproterone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000627:therapeutic use*; D017273:Goserelin; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D017273:Goserelin; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol; D003534:Cyproterone; D002064:Buserelin